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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by abnormal
cellular responses to cigarette smoke, resulting in tissue destruction and airflow limitation. Autophagy is a degradative
process involving lysosomal turnover of cellular components, though its role in human diseases remains unclear.
Methodology and Principal Findings: Increased autophagy was observed in lung tissue from COPD patients, as indicated by
electron microscopic analysis, as well as by increased activation of autophagic proteins (microtubule-associated protein-1 light
chain-3B, LC3B, Atg4, Atg5/12, Atg7). Cigarette smoke extract (CSE) is an established model for studying the effects of cigarette
smoke exposure in vitro. In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly
induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F
factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-
induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion.
Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1
2/2 mice, which
displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema.
Conclusions: We demonstrate a critical role for Egr-1 in promoting autophagy and apoptosis in response to cigarette smoke
exposure in vitro and in vivo. The induction of autophagy at early stages of COPD progression suggests novel therapeutic
targets for the treatment of cigarette smoke induced lung injury.
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Introduction
Chronic obstructive pulmonary disease (COPD) is defined as a
preventable and treatable disease state characterized by airflow
limitation that is not fully reversible. The airflow limitation is
usually progressive and is associated with an abnormal inflamma-
tory response of the lungs to noxious particles or gases [1].
Cigarette smoking is the most important risk factor for the
development of COPD [2]. However, only 10–15% of smokers
develop the disease, implying genetic factors may increase the risk
in certain individuals [3]. The cellular and molecular mechanisms
for COPD pathogenesis remain incompletely understood [4].
Gene expression profiling studies of human clinical COPD lung
tissue have suggested candidate molecular targets for disease
progression and therapeutic intervention [5–6]. In our recent
comprehensive gene expression analyses, we found a number of
genes that were differentially expressed between COPD smokers
with and without lung function impairment. Among these, we
identified the early growth response-1 (Egr-1) as a gene whose
expression changed significantly in COPD [6]. Egr-1 is a zinc
finger transcription factor classified as an immediate-early
response protein, which is potentially induced by a variety of
cellular stressors [7]. Egr-1 regulates the expression of many genes,
including repair enzyme systems, angiogenic factors, cytokines,
apoptotic factors, cell cycle factors, metabolic factors and proteases
[8]. The role of Egr-1 in the pathogenesis of COPD remains
incompletely understood.
Recent studies have implicated other epigenetic factors
potentially involved in COPD progression, among which include
histone deacetylases (HDAC)[9–10]. HDACs belong to a family of
nuclear enzymes that modify the expression of inflammatory genes
by regulating chromatin structure [10]. Acetylation of core
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3316histones leads to changes in chromatin structure that subsequently
allow transcription factors and RNA polymerase II to bind to
DNA and enhance gene transcription. Conversely, deacetylation
of histones is generally associated with the repression of
transcription. HDACs can also modulate the acetylation state
and activity of major transcription factors [10]. The relationship
between HDAC activity and the regulation of Egr-1 is currently
unknown.
Programmed cell death mechanisms may contribute signifi-
cantly to lung cell death and tissue injury following exposure to
cigarette smoke, though their role in COPD pathogenesis remains
unclear [11]. Recent examination of lung tissue from COPD
patients reveals the presence of apoptotic cells in greater numbers
than in control lungs or those from smokers without COPD [12–
13]. Apoptotic cells include alveolar and bronchial epithelial cells
as well as endothelial cells in the parenchyma. In rodents,
induction of endothelial or epithelial apoptosis is accompanied by
loss of pulmonary alveoli and pathological evidence of emphyse-
matous changes [14]. Blockade of the vascular endothelial growth
factor receptors caused alveolar cell apoptosis, oxidative stress and
emphysema-like disease in both rats and mice [15]. This evidence
suggests that apoptosis is a crucial step in emphysema and COPD.
Autophagy is a dynamic process responsible for the turnover of
cellular organelles and long-lived proteins. During autophagy,
cytosolic proteins and organelles (e.g., mitochondria and endoplas-
mic reticulum) are engulfed into double-membrane bound vesicles
(autophagosomes or autophagic vacuoles). The outer membrane of
the autophagosome subsequently fuses with lysosomes to form
autolysosomes in which the engulfed components are degraded by
lysosomal hydrolases, regenerating metabolic precursors that are
recycled for macromolecular synthesis and ATP generation.
Autophagy is induced above basal levels in response to diverse
stimuli including nutrient starvation, genotoxic agents, cytokines,
and oxidative stress. This process provides an essential function in
the maintenance of cellular homeostasis and adaptation to adverse
environments. Under certain conditions, however, excessive
autophagy may promote cell death [16–17]. Genes critical for
the regulation of autophagy were initially discovered in yeast,
though recently, extensive investigation has been done in
mammalian systems since the discovery of their eukaryotic
homologs [16–17]. The regulation and functional significance of
autophagy in human tissues under physiological or pathological
conditions remains incompletely understood. Furthermore, noth-
ing is currently known of the possible role of autophagy in
emphysema and COPD.
We report here for the first time that increased autophagy is
associated with cigarette smoke-induced lung injury and COPD.
We sought to determine the specific relationships between
epigenetic factors, such as HDAC activities and Egr-1, which
are modulated by cigarette smoke, and their roles in the regulation
of autophagy by cigarette smoke. The current study demonstrates
that cigarette smoke-dependent decreases in HDAC activity are
functionally linked to the induction of autophagy. HDAC
inhibition increases the expression of microtubule-associated
protein-1 light chain-3B (LC3B), a key mediator of autophagy.
We show that this process involves an HDAC-dependent
regulation of E2F and Egr-1 transcription factors, which
cooperatively regulate the LC3B promoter. Egr-1 is also essential
for the regulation of Atg4B, which regulates the activation state of
LC3B. We identify Egr-1 as an important regulator of lung cellular
and tissue responses to cigarette smoke exposure. Our results
implicate Egr-1 as a key mediator of cigarette smoke-induced
autophagy and apoptosis in vitro and in vivo, and thereby
demonstrate a critical role for Egr-1 in COPD pathogenesis.
Results
Increased autophagy in human COPD lung tissues
To investigate the role of autophagy in the pathogenesis of
COPD, lung tissue sections from control or COPD patients were
analyzed for the expression of autophagy proteins. In mammals,
the conversion of LC3B from LC3B-I (free form) to LC3B-II
(membrane-bound form) is regarded as a key step in the induction
of autophagy [16–17]. The ratio of LC3B-II/LC3B-I, as well as
the expression of Atg4B, Atg5-Atg12 and Atg7 were significantly
increased in COPD lung (Fig. 1A). Electron microscopy (EM), a
gold-standard method for determination of autophagy, revealed
that autophagic vacuoles (autophagosomes/autolysosomes) were
dramatically increased in COPD lung tissues, whereas little
vacuole formation was evident in control tissues (Fig. 1B).
Immunofluorescence staining indicated that the expression of
LC3B was significantly increased in COPD lung tissues (Fig. 1C).
Immunohistochemical staining of COPD lung tissue indicated that
LC3B expression was localized to epithelial cells and macrophages
(data not shown). Examination of various stages of COPD, according
to the Global Initiative for Obstructive Lung Disease (GOLD) for
classifying disease severity in COPD, revealed elevations of these
markers at GOLD0 which were sustained throughout the disease
progression (GOLD2-4), (Fig. 1A), suggesting that autophagy
represents a response to cigarette smoke exposure, as well as an
early event in the progression of emphysema. Lungs from patients
with a-1 anti-trypsin deficiency (a1AT), the genetic cause of
emphysema, also showed significant induction of autophagy
(Table 1). However, lungs from patients with other pulmonary
diseases, including idiopathic pulmonary fibrosis, cystic fibrosis,
sarcoidosis, and systemic sclerosis, showed no significant elevation
of autophagy (Table 1).
Apoptosis in COPD lung tissues
Autophagy represents a cellular adaptive mechanism that
promotes survival under various stress conditions including
nutrient deprivation [16–17]. However, excessive autophagy can
influence several forms of cell death, including caspase-indepen-
dent cell death and apoptosis [18–24]. We therefore examined
apoptotic markers in COPD patients, as increasing evidence
suggests that apoptosis plays a pivotal role in the pathogenesis of
COPD [11–15]. Analysis of lung tissues from different stages of
COPD revealed that Caspase-3 activity was only significantly
elevated in GOLD3/4 (Fig. 1D). These data suggest that apoptosis
occurs later than autophagy during the development of emphy-
sema and COPD.
Cigarette smoke exposure increases epithelial cell
autophagy
Although CSE exposure cannot replicate the complex effects of
long term cigarette smoking in an in vivo system, it facilitates the
testing of human and mouse lung derived cells for responses to the
ingredients contained in cigarette smoke. We studied the induction
of autophagy by CSE in a human pulmonary cell line and in
primary cell cultures. Biochemical studies revealed a dose-
dependent induction of LC3B-II/LC3B-I ratio by CSE in human
bronchial epithelial (HBE) cells grown in air-liquid interface
cultures, as well as in cultured SAE and Beas-2B cells (Fig. 2A).
While some variations were detected in basal LC3B-I levels among
the cell lines, all lines displayed increased LC3B-II levels with 1%
CSE exposure. Furthermore, the induction of LC3B-II levels by
CSE in HBE cells was enhanced by bafilomycin A1 (Fig. 2A), a
compound that prevents the maturation of autophagic vacuoles by
inhibiting autophagosome-lysosome fusion [25]. EM analysis of
Autophagy in COPD
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3316Figure 1. Autophagy and apoptosis in Lung Tissues from COPD Patients. (A) Western blot analysis and corresponding quantification of
autophagy related proteins, LC3-II/LC3-I, Atg4, Atg5-atg12 and Atg7, in human lung tissues from normal and COPD patients. Images are
representative blots of the corresponding proteins. The sample numbers analyzed by densitometry for each group are: Normal (n=12), G0 (n=12),
G2 (n=12), G3/4 (n=20). b-Actin served as the standard. (B) Representative EM study of human lung sections from a nonsmoker or COPD patient. M
indicates mitochondria. AVi indicates immature autophagic vacuoles (autophagosomes). AVd indicates degradative, late autophagic vacuoles
(autolysosomes). (Insert, Right) Peripheral lung epithelial cells were scored for number of immature autophagic vacuole (AVi) and degradative
Autophagy in COPD
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CSE as early as 4 h (Fig. 2B). GFP-LC3 fluorescence was used to
monitor autophagy in Beas-2B cells transiently transfected with an
expression vector for GFP-LC3 [26]. The formation of GFP-LC3-
labeled puncta, representing association of LC3B-II with autop-
hagosomes (27), was extensively induced in cells exposed to CSE
(Fig. 2C). We examined whether the induction of autophagy by
CSE was related to altered cellular redox homeostasis. We have
observed that CSE increased ROS levels in Beas-2B cells. CSE
induced autophagy was significantly attenuated in the presence of
NADPH: oxidase inhibitors, diphenylene iodonium or apocynin,
or the antioxidant, N-acetyl-L-cysteine (Fig. 2D).
Relationship of autophagy and apoptosis in cigarette
smoke exposure
Increasing evidence suggests crosstalk between apoptosis and
autophagy, as several apoptosis-related factors are critically involved
in autophagy [21–23]. Inhibition of apoptosis may trigger
autophagy, [18–19] whereas inhibition of autophagy may either
induce or attenuate apoptosis [22–24]. We therefore examined the
functional significance of autophagy in relationship to cell death
caused by cigarette smoke. Inhibition of LC3B by siRNA attenuated
CSE-induced cytotoxicityinBeas-2Bcells (Fig.3A).InLC3B-siRNA
treated cells, CSE-induced cell apoptosis was also significantly
inhibited, as revealed by the decreased number of apoptotic cells as
well as reduced caspase-3 activation and poly (ADP-ribose)
polymerase (PARP) cleavage (Figs. 3B and 3C).
Decreased HDAC activity regulates autophagy in
response to cigarette smoke exposure
Recent studies have shown decreased HDAC activity as well as
HDAC protein levels in COPD and in cells exposed to cigarette
smoke extract (CSE) [9,28–29]. Since the inhibition of HDAC
activity can induce both apoptotic and autophagic cell death in
vitro [30], we hypothesized that decreased HDAC activity in
COPD may also trigger autophagy. Consistently, we found that
HDAC activity was significantly reduced in COPD (Fig. 4A), and
dose-dependently decreased by CSE in Beas-2B cells (Fig. 4B). In
human COPD, acetylation of histones H2A, H2B, H3, and H4
was increased (Fig. 4C). Tricostatin-A (TSA), the inhibitor of
HDAC, significantly induced autophagy, as revealed by increased
LC3B expression (Fig. 4D) and GFP-LC3 puncta, at pharmaco-
logical concentrations (Fig. 2C).
Regulation of LC3B by Egr-1
Our laboratory has previously performed comprehensive gene
expression analyses which have indicated that the transcriptional
regulator early growth response-1 (Egr-1) represents one of the
major genes that are significantly upregulated in COPD lung
tissue [6]. We have also previously shown that Egr-1 protein
expression is increased in normal human lung fibroblasts cells after
exposure to CSE in a dose- and time-dependent manner [6]. We
therefore tested whether a similar response could be observed in
pulmonary epithelial cells. Treatment of Beas-2B cells with CSE
(10%) induced the time-dependent expression of Egr-1 protein,
with an apparent maximum at 60 min of exposure time (Fig. 5A).
Similar results were observed in HBE and SAE cells (Fig. 5A). We
hypothesized that Egr-1 may play a role in the regulation of
autophagy genes such as LC3B and Atg4B. Genetic inhibition of
Egr-1 (Fig. 5B) by siRNA significantly attenuated CSE- and TSA-
inducible LC3B and Atg4B expression. Lung fibroblasts derived
from Egr-1
2/2 mice also showed remarkably attenuated expres-
sion of LC3B and Atg4B (Fig. 5C) in response to CSE or TSA.
Since little is known about the transcriptional regulation of the
LC3B gene, we sought to identify possible regulatory factors of this
autophagy gene. Genetic analysis of the promoter region of LC3B
revealed several candidate transcription factor binding sites,
including binding sites for Egr-1 and E2F (see Fig 6A and Materials
and Methods). Chromatin immunoprecipitation assays revealed that
Egr-1 and E2F-4 were rapidly induced to bind the LC3B promoter
under stimulation by CSE or TSA in Beas-2B cells (Fig. 6B).
HDACs form complexes with and thereby regulate the activity of
members of the E2F family of transcription factors, important
regulators of cell cycle progression and proliferation [31–33]. We
Table 1. Relative expression of autophagic proteins in human lung tissues.
Normal GOLD0 GOLD2 GOLD3/4 CF a1AT Sarc SSc IPF
(n=12) (n=12) (n=12) (n=20) (n=10) (n=7) (n=4) (n=6) (n=18)
LC3-II/LC3-I 5.7565.24 11.1064.21
# 15.1366.67
# 11.4066.30
# 2.6161.63 12.2164.88
# 3.2561.69 1.5161.47 1.9061.40
Atg4 0.06760.064 0.4760.16* 0.4860.18* 0.4060.24* 0.1260.12 0.2160.15 0.1860.16 0.2260.18 0.3560.19
#
Atg5-atg12 0.4060.29 0.6160.13
# 0.6360.23
# 0.6760.32
# 0.4360.20 0.2660.08 0.4060.17 0.4360.14 0.4660.13
Atg7 0.3260.13 0.4560.14
# 0.4760.12
# 0.4660.14
# 0.3160.19 0.4960.11
# 0.3460.11 0.3160.21 0.3860.18
Table 1 shows the quantified Western blot analysis of Autophagy-related proteins, LC3-II/LC3-I, Atg4, Atg5-atg12 and Atg7, in human lung tissues from normal patients,
from various stages of COPD (GOLD0, GOLD2, GOLD3/4) and from patients with various representative lung diseases, including cystic fibrosis (CF), alpha-1 anti-trypsin
deficiency (a1-AT), sarcoidosis (SARC), systemic sclerosis (SSc), and interstitial pulmonary fibrosis (IPF). The sample numbers analyzed for each group are: Normal (n=12),
G0 (n=12), G2 (n=12), G3/4 (n=20), IPF (n=18), CF (n=10), Sarc (n=4), SSc (n=6) and a1AT (n=7). Data represent mean6SD. Atg4, Atg5-atg12 and Atg7 data were
normalized to b-actin.
*p,0.01 compared with normal group.
#p,0.05 compared with normal group.
doi:10.1371/journal.pone.0003316.t001
autophagic vacuoles (AVd). The data are represented as AVi and AVd per 100 mm
2. Data are mean scores plus standard deviation. N=30 images
representative of COPD lung, and N=15 images representative of control, at same magnification. *P,0.05 (C) Representative immunofluorescence
staining of human lung sections from normal and COPD patient. Upper two images are tissues stained with Phalloidin (green), indicating the lung
alveolar structure. Lower two images are tissues stained with LC3 (red). Images are at 2006and 6006(insets). White arrow indicates the immune cells
and white arrowhead indicates epithelial cells. (D) Caspase-3 activity of lung tissues from normal and various stages of COPD patients (n=10). (B, D)
Data represent mean+/2S.D. *indicates P,0.05, ** indicates P,0.01.
doi:10.1371/journal.pone.0003316.g001
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the potential regulation of LC3B by E2F and Egr-1 factors. E2F-4
formed a complex with Egr-1 following cellular stimulation with
CSE or the HDAC inhibitor TSA (Fig. 6C). Consistent with our
observations of reduced HDAC activity in CSE-treated Beas-2B
cells, we have observed increased acetylation of Egr-1 protein in
response to CSE treatment (Fig. 6D). Genetic inhibition of E2F-4 by
siRNA significantly attenuated CSE- and TSA-inducible LC3B
expression (Fig. 6E), whereas did not alter the expression of Egr-1
(Fig. 6E).
Figure 2. Increased Autophagy by CSE in Pulmonary Epithelial Cells. (A) Western blot analysis of LC3 in CSE-treated HBE, SAE, and Beas-2B
cells. Cells were treated with various concentrations of CSE for 24 h. Far right panel shows that bafilomycin A1 enhanced the CSE-induced LC3
expression in HBE cells. Cells were pretreated with 200 nM Bafilomycin A1 for 30 min and followed by the exposure to 30% CSE for an additional
24 h. (B) Formation of autophagic vacuoles in HBE cells treated with 1% CSE for 4 h. N indicates nuclei. AVi, immature autophagic vacuoles
(autophagosomes), AVd, degradative, late autophagic vacuoles (autolysosomes). (Right) EM images corresponding to HBE cell exposed to 10% CSE
for 24 h scored for number of immature autophagic vacuole (AVi) and degradative autophagic vacuoles (AVd). The data are represented as AVi and
AVd per 100 mm
2. Data are mean scores plus standard deviation. N=15 images representative of CSE treated cells, and N=10 images representative
of control cells, at same magnification. *P,0.05 (C) Representative images of the punctuated GFP-LC3 in Beas-2B cells treated with 5% CSE or 50 nM
TSA for 24 h. White bar indicates 10 mm. (D) Increased ROS accumulation in CSE-treated Beas-2B cells. Cells were exposed to 20% CSE for 1 h. (Right)
CSE-induced LC3 expression was attenuated by diphenyliodonium (DPI), Apocynin or N-acetyl-L-cysteine (NAC). Beas-2B cells were pretreated with
the antioxidant at the indicated concentrations for 30 min and followed by the exposure to 30% CSE for an additional 24 h. Data represent mean+/
2S.D. of three independent experiments. ** indicates P,0.01.
doi:10.1371/journal.pone.0003316.g002
Autophagy in COPD
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and emphysema in response to cigarette smoke
exposure in vivo
To assess the role of Egr-1 in human disease, we also examined
Egr-1 protein expression in COPD human lung tissue specimens.
Egr-1 protein expression was elevated at all stages of COPD relative
to normal controls (Fig. 7A). The expression of Egr-1 was increased
in C57Bl/6 mouse lung tissue after 12 or 24 weeks of chronic
cigarette smoke exposure relative to air-exposed controls (Fig. 7B).
Egr-1
2/2 mice displayed attenuated activation of LC3B
(Fig. 8A), Atg4B expression (Fig. 8B) and apoptotic factors (e.g.,
Bax/Bcl-2 ratio)(Fig. 8C) in response to prolonged (6 mo) cigarette
smoke exposure relative to wild-type counterparts. Egr-1
2/2 mice
basally exhibited airspace enlargement as assessed by mean linear
intercept (MLI) [34], relative to corresponding wild-type controls,
whose magnitude exceeded that of cigarette smoke-exposed wild-
type mice. Chronic smoke exposure did not modulate airspace
enlargement as assessed by MLI and H+E staining in Egr-1
2/2
mice (Fig. 8D and E). These results indicate that Egr-1
2/2 mice,
which displayed basal airspace enlargement, resisted cigarette-
smoke induced autophagy and apoptosis, as well as further
changes in airspace enlargement as assessed by MLI.
Discussion
Here, we provide the first evidence of cigarette smoke-induced
autophagy in human COPD, in pulmonary epithelial cells, and in
mice exposed to chronic cigarette smoke. We also examined the
relationship between autophagy and apoptosis in response to
cigarette smoke. We have observed that blockage of autophagy by
LC3B-siRNA attenuated CSE-induced epithelial cell apoptosis
and consequently increased cell viability, suggesting that autoph-
agy functioned as a mediator of apoptosis in this model.
Consistently, autophagy was induced at very low CSE concentra-
tions (as low as 1%) and at earlier times (as early as 4 h)(Fig. 2B).
In COPD patients, as early as GOLD0, there was dramatic
increase of autophagy and autophagic proteins (Figs. 1A–C) which
was evident throughout the disease progression (up to GOLD4),
whereas caspase-3 activation occurred only at later stages (Fig. 1D).
These findings, taken together, suggest that autophagy is an
essential and early response to cigarette smoke which mediates
apoptosis and eventually promotes cell death, thereby potentially
playing an important role in COPD pathogenesis.
Some limitations exist in the use of CSE to study in vitro
responses to cigarette smoke, including exclusion of some volatile
components present in cigarette smoke, and variations in the
preparation method in between individual laboratories. Never-
theless CSE remains a useful model of in vitro smoke exposure that
has the potential to uncover important biological pathways [35]. It
should be mentioned that the CSE concentrations used in our
present study appear to be higher than other previous reports by
other investigators. In previous work, CSE is typically prepared in
serum free medium, and used in cultures preconditioned with
serum free media. In our present study, we compose our CSE in
complete culture medium to avoid induction of autophagy
through the serum starvation pathway. Higher CSE concentra-
tions are apparently required for apoptosis and cell death in
complete medium relative to serum free media.
Epigenetic factors have recently come into focus as possible
mechanisms underlying susceptibility to COPD in certain individ-
uals [36]. Surgically resected lung tissue from nonsmokers or
GOLD0-4 smokers, showed significant decreases of HDAC activity
in COPD lung tissue relative to nonsmokers whose magnitude
correlated with disease severity and inflammatory gene expression
[9]. In addition to lung tissue, HDAC activity was also decreased in
alveolar macrophages from bronchoalveolar lavage samples of
COPDpatients[9].Furthermore,the expression of HDAC2mRNA
and protein in peripheral lung tissue and bronchoalveolar lavage
macrophages, declined as a function of disease progression [9].
Consistent with these prior studies, we have observed decreased
HDAC activity in human COPD lung tissue. Furthermore, we show
that the acetylation of major histones was increased in COPD lung
tissue. Exposureto CSE dose-dependently decreased HDAC activity
inpulmonaryepithelialcells invitro (Fig. 4B). While HDAC activity is
generally associated with transcriptional repression, through the
deacetylation ofhistones, HDACsmay alsomodulate theacetylation
state of major transcription factors, and thus have complex effects on
gene regulation. Previously, these activities have been linked to the
regulation of pro-inflammatory gene expression in chronic lung
diseases [36]. Here, we have suggested a link between HDAC
modulation and the regulation of autophagy, as the HDAC inhibitor
Figure 3. Relationship of autophagy to epithelial cell death. (A–
C) Beas-2B cells were pretreated with C-siRNA or LC3-siRNA for 48 h
followed by exposure to the indicated concentrations of CSE for an
additional 24 h. Cells were then subjected to MTT assay (A), Annexin-V
staining (B) or Western blot analysis (C). (A) LC3-siRNA attenuated CSE-
induced cytotoxicity in Beas-2B cells. (B) LC3-siRNA inhibited CSE-
induced apoptosis in Beas-2B cells. (C) LC3-siRNA attenuated CSE-
induced caspase-3 activation and PARP cleavage. (A, B) Data represent
mean6SD, (n=3, * indicates P,0.05 and ** indicates P,0.01 compared
with the corresponding control data).
doi:10.1371/journal.pone.0003316.g003
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3316Figure 4. Role of HDAC Activity in COPD and Autophagy. (A) Decreased HDAC activity in lung tissues from COPD patients (n=5). (B) CSE-
dependent reduction of HDAC activity in Beas-2B cells. Cells were treated with various concentrations of CSE for 24 h and subjected for analysis of
HDAC activity. (C) Western blot analysis of acetylated histones in human lung tissues. (D) Induction of LC3 by TSA in Beas-2B cells. Cells were treated
with the indicated concentrations of TSA for 24 h. (B–C) Data represent mean+/2S.D. of three independent experiments. *indicates P,0.05, **
indicates P,0.01.
doi:10.1371/journal.pone.0003316.g004
Figure 5. Expression of LC3B requires Egr-1. (A) Beas-2B, HBE, or SAE cells were treated with 10% CSE, for the times indicated and assayed for
the expression of Egr-1 by Western immunoblot analysis. Images are representative of 3 independent experiments. (B) Beas-2B cells were pretreated
with control siRNA (C-siRNA), or Egr-1 siRNA for 48 h, followed by the treatment with 20% CSE or 100 nM TSA for an additional 24 h. Cells were then
harvested for Western blot analysis. b-Actin served as the standard. (C) Lung fibroblasts derived from wild type C57BL/6 or Egr-1
2/2 mice were
treated with 20% CSE or 100 nM TSA for 24 h. Lysates were analyzed by Western immunoblotting for LC3, or Egr-1. b-Actin served as the standard.
doi:10.1371/journal.pone.0003316.g005
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PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3316Figure 6. Regulation of LC3B by Egr-1 and E2F-4. (A) Putative Egr1 and E2F4 binding sites in the LC3b promoter. PCR primer locations for the
CHIP analysis are labeled by arrows. Putative E2F4 (E1 to E7) and Egr1 (R1 to R4) binding sites are indicated as light and dark blue bars, respectively.
The nucleotide locations for putative E2F1 and Egr1 sites are shown in Figure S1. (B) Increased DNA binding of E2F-4 and Egr-1 to the LC3B promoter
by CSE and TSA. Beas-2B cells were treated with 20% CSE or 100 nM TSA for 1 h and subjected to CHIP assay as described in Methods. Chromatin
samples were immunoprecipitated with anti-E2F-4 or anti-Egr-1 and evaluated for factor binding to the LC3B promoter region. (C) Beas-2B cells were
treated with 20% CSE or 100 nM TSA for 1 h. Lysates were immnuoprecipitated (IP) with anti-E2F-4 and immunoblotted (IB) with anti-Egr-1. IgG
served as the standard. CSE and TSA increased E2F-4 and Egr-1 complex formation. (D) Beas-2B cells were treated with 20% CSE for 24 h. Lysates were
immunoprecipitated (IP) with anti-pan acetyl antibody and immunoblotted (IB) with anti-Egr-1. IgG served as the standard. CSE increased acetylation
of Egr-1. (E) Effect of E2F-4 on the CSE- and TSA-induced LC3B expression. Beas-2B cells were pretreated with control siRNA (C-siRNA), E2F-4-siRNA,
LC3B siRNA for 48 h, followed by the treatment with 20% CSE or 100 nM TSA for an additional 24 h. Cells were then harvested for Western blot
analysis. b-Actin served as the standard.
doi:10.1371/journal.pone.0003316.g006
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autophagy in vitro (formation of LC3 puncta, and increased LC3B
expression and conversion). Decreases in HDAC led to increases in
complex formation between the transcription factor Egr-1 and its
coactivator E2F-4, both which displayed increased binding at the
LC3B promoter (Fig. 6). While HDACs have previously been shown
to regulate E2F factors [31–33], we demonstrate that Egr-1 is also
regulated by HDAC, such that increased acetylation of the protein
was detected with CSE treatment. Our current findings strongly
demonstrated a central role of E2F-4 and Egr-1 in regulation of
LC3B expression, and thereby also suggest novel targets for
regulating autophagy in mammalian systems.
We also demonstrate that Egr-1 is essential for the upregulation
of Atg4B by cigarette smoke (Fig 5B and C). Atg4B is essential in
the cleavage of pro-LC3B to LC3B-I, as a prerequisite for the
conjugation of LC3B-I with phosphatydylethanolamine by Atg3/
Atg7 ligases. Atg4 plays a dual role in that it also catalyzes the
deconjugation of LC3B-II during late stage autophagy [37].
Therefore we conclude that Egr-1 directly regulates LC3B
expression by transcriptional regulation of the gene, and also
indirectly regulates LC3B conversion through regulation of Atg4B.
Egr-1 is expressed in the mouse lung in response to cigarette
smoke exposure and also in vitro in response to CSE exposure
(Fig 5A and 7B). We have shown here that elevated Egr-1
expression is also evident in human clinical samples of COPD at
all stages of disease progression (Fig. 7A). Recent studies from this
laboratory have revealed that Egr-1 may play a role in cigarette
smoke induced lung pathophysiology by regulating the expression
of matrix metalloproteinase-2, a candidate molecule in emphyse-
ma development [6]. We have further shown here that Egr-1
2/2
mice are resistant to the pro-apoptotic and pro-autophagic effects
of smoke inhalation, as well as cigarette smoke-induced airspace
enlargement as assessed by MLI. However, Egr-1
2/2 mice basally
exhibited airspace enlargement, relative to corresponding wild-
type controls (Fig. 8). Since chronic cigarette smoke exposure did
not promote further increases in airspace enlargement in Egr-1
2/2
mice, these mice were apparently resistant to smoke-induced
injury. While Egr-1 plays an important role in mediating cigarette
smoke-induced autophagy and apoptosis in vitro, this factor, as
suggested by previous studies [38], exerts a dominant role in lung
homeostasis and growth in vivo. Thus, Egr-1
2/2 mice reach a
critical threshold of airspace enlargement under basal conditions
such that further histologic changes induced by cigarette smoke
are not evident in vivo. Examination of the role of Egr-1 in lung
development may be worthy of further investigation.
To demonstrate the pivotal role of autophagy in COPD
pathogenesis, further experimentation with autophagy gene
knockout mice may be warranted. However, to date, no such
mice have been used for in vivo models of lung disease. Atg5
2/2
and Beclin-1
2/2 mice are embryonic lethal [39–40]. Beclin-1
+/2
mice easily develop carcinoma [40], limiting their usefulness as a
model. LC3B
2/2 knockout mice have been developed recently
[41], but autophagy can still occur in such mice by compensatory
mechanisms. Nevertheless, the use of autophagy-deficient mice
will be the focus of future investigation.
In conclusion, we provide the first evidence that autophagy
occurs as an early event in COPD progression, and in epithelial
cell responses to cigarette smoke exposure. Inhibition of autophagy
protected against apoptosis induced by cigarette smoke. While
autophagy has been recently studied in experimental models of
human disease [42], very few studies have examined this process in
clinical samples of human diseased tissue. Recent observations in
inflammatory bowel disease suggest that genetic polymorphisms in
autophagy genes may be linked to the progression of this disease
[42]. Specifically, a small nucleotide polymorphism of the atg-16L1
gene has been associated with increased susceptibility to Crohn’s
disease [43–44].
We propose a mechanistic pathway for the early events in the
development of COPD (Fig. 9). We show that decreased HDAC
activity in COPD [9], is linked with the induction of autophagy.
The activation of E2F-4 and Egr-1 transcription factors by HDAC
inhibition induced the expression of the autophagic regulator
LC3B. Furthermore we demonstrate that Egr-1 plays a critical role
in cigarette smoke-induced autophagy and apoptosis.
Materials and Methods
Patients
All human lung tissues were obtained from either lung
transplantation explant tissues or from lung resection from
thoracic surgical cases. These lung sections are processed
immediately after obtaining from thoracic surgeons (co-authors
Drs. Rodney J. Landreneau, Mathew J. Schuchert) by the Tissue
Core (co-author Dr. Joe Pilewski, director of Tissue Core). The
isolated lung tissues are snap frozen and stored in 280uC freezers,
and stored at the core facility at the Thoracic Center of Excellence
(COE) in Anatomic Pathology at the University of Pittsburgh
(directed by Drs. Samuel Yousem and Rajiv Dhir, both co-authors
Figure 7. Expression of Egr-1 in vitro and in vivo in response to
cigarette smoke. (A) Lung tissue samples from various stages of
COPD (GOLD0 to GOLD3/4) were analyzed for expression of Egr-1 in
lung tissue by Western immunoblot analysis, and normalized to b-actin
expression. (B) C57BL/6 were exposed to chronic cigarette smoke
exposure (black bars) or air (grey bars) for 12 or 24 weeks and Egr-1
expression in the lung was determined by Western immunoblot
analysis. b-Actin served as the standard. (n=12). *indicates P,0.05,
**indicates P,0.01. N.S., not significant.
doi:10.1371/journal.pone.0003316.g007
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Emphysema Research Center, and co-author) at the University of
Pittsburgh for clinical and phenotypic data. This described state of
the art tissue sampling infrastructure has been immensely
successful in obtaining the highest quality lung tissues for RNA
and protein analyses.
We followed the guidelines of the Global Initiative for Obstructive
Lung Disease for classifying disease severity in COPD [45]. The
Figure 8. Role of Egr-1 in the regulation of autophagy, apoptosis, and emphysema in vivo during chronic cigarette smoke exposure.
(A–C) Wild type C57BL/6 or Egr-1
2/2 mice were exposed to chronic cigarette smoke exposure for 6 months (each group n=5). Lung tissue
homogenates were analyzed for (A) expression of LC3, (B) expression of Atg4B, (C) Bax/Bcl2 ratio. Lung tissue was evaluated for emphysema/airspace
enlargement and mean linear intercept (D) and H+E staining (E).
doi:10.1371/journal.pone.0003316.g008
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years; the majority were ex smokers. The smoking history of the
GOLD 0/2 group was an average of 50 pack years; .60% were ex
smokers. The normal lung was obtained from non-smokers.
Animals
All animals were housed in accordance with guidelines from the
American Association for Laboratory Animal Care. The Animal
Care and Use Committee of the University of Pittsburgh approved
the protocols. C57/BL6 mice (Jackson Laboratories, Bar Harbor,
ME) or Egr-1 deficient (egr-1
2/2) mice (Taconic, Hudson, NY)
were exposed to cigarette smoke (CS) or filtered air under identical
conditions beginning at 8 wks of age. Mice were exposed 5 d/week
for 24 weeks.
In vivo cigarette smoke exposure
Total body cigarette smoke exposure was performed in a
stainless steel chamber (71 cm661 cm661 cm) using a smoking
machine (Model TE-10, Teague Enterprises). The smoking
machine puffs each 1R3F cigarette for 2 seconds, for a total of 9
puffs prior to ejection, at a flow rate of 1.05 l/min, providing a
standard puff of 35 cm
3. The smoke machine was adjusted to
deliver 5 cigarettes at one time. Mice were exposed 5 d/week for
24 weeks. The chamber atmosphere was periodically measured for
total particulate matter concentrations of 100–120 mg/m
3.
Carboxyhemoglobin levels in the C57/BL6 strains of mice after
two weeks of cigarette exposure were typically less than 8%
immediately following exposure.
Lung morphometry
Mean linear intercept measurements were obtained using
modified Image J software available from the National Institute
of Health website (http://rsb.info.nih.gov/ij/). Immediately
following necropsy, the right lung was inflated by gravity with
4% paraformaldehyde and held at a pressure of 30 cmH20 for
15 minutes. The left lung was removed and immediately stored in
liquid nitrogen for subsequent protein studies.
The right lung was gently dissected from the thorax and placed
in 4% paraformaldehyde for up to 8 h. The samples were cut
para-sagitally and embedded in paraffin. Modified Gills staining
was performed and twelve random 130061030 pixel images were
acquired digitally for each lung sample using a light microscope
(Zeiss Axiophot, Carl Zeiss MicroImaging, Thornwood, NY)
equipped with a digital camera (Zeiss Axiocam HRc, Carl Zeiss
MicroImaging, Thornwood, NY) at 2006 magnification. Large
airways, blood vessels, and other non-alveolar structures were
manually removed from the images. The Image J software
program automatically thresholded the images, and a Median
filter, set to a 2 pixel radius, was run to smooth the image edges.
The program laid a line grid comprised of 1353 lines with each
line measuring 21 pixels over the individual images. The software
then counted the number of lines that ended on or intercepted
alveolar tissue. These data were used to calculate the volume of
air, the volume of tissue, the surface area, the surface area to tissue
volume ratio. The mean linear intercept, which assesses the degree
of alveolar airspace enlargement, was calculated using the
equation: (4/surface area to volume tissue ratio) according to
methods adapted from Dunhill [34]. The mean linear intercept
increases with increasing airspace enlargement.
Cell culture
Human lung epithelial Beas-2B cells were maintained in DMEM
containing 10% fetal bovine serum and antibiotics. The primary
human small airway epithelial (SAE) cells were obtained from
American Type Culture Collection (ATCC, Manassas, VA) and
were cultured according to the ATCC prescription. The primary
human bronchial epithelial (HBE) cells were cultured in air-liquid
interface from excess pathological tissue following lung transplanta-
tion and organ donation under a protocol approved by the
University of Pittsburgh Investigational Review Board, as previously
described [46]. For preparation of cigarette smoke extract (CSE),
Kentucky 1R3F research-reference filtered cigarettes (The Tobacco
Research Institute, University of Kentucky, Lexington, KY) were
smoked using a peristaltic pump (VWR International). Prior to the
experiments, the filters were cut from the cigarettes. Each cigarette
was smoked in 6 minutes with a 17 mm butt remaining. Four
cigarettes were bubbled through 40 ml of cell growth medium, and
this solution, regarded as 100% strength CSE, was adjusted to a pH
of 7.45 and used within 15 minutes after preparation.
Cell viability was determined by the conventional 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
assay and the apoptotic cell death was determined by Annexin V
staining.
Transmission electron microscopy and fluorescence
microscopy
Lung tissue sections were fixed in formalin and embedded in
paraffin. Cells were fixed in 2.5% glutaraldehyde in PBS after
experimental manipulations. These tissues or cells were photo-
graphed using a JEOL JEM 1210 transmission electron micro-
scope (JEOL, Peabody, MA) at 80 or 60 kV onto electron
microscope film (ESTAR thick base; Kodak, Rochester, NY) and
printed onto photographic paper. To examine the distribution of
GFP-LC3B, cells were observed under a fluorescence microscope
and digital images were acquired for analysis (SPOT, Diagnostic
Instruments, Inc.).
Immunofluorescence staining
Formalin-fixed, paraffin-embedded lung tissue sections were
subject to immunofluoresence staining with anti-LC3. Samples
were viewed with an Olympus Fluoview 300 Confocal Laser
Scanning head with an Olympus IX70 inverted microscope. For
Figure 9. Epigenetic regulation of autophagy by cigarette
smoking. The scheme shows the proposed pathway for epigenetic
regulation of autophagy by cigarette smoke exposure. Suppression of
HDAC activity leads to the increased transcription of the LC3B promoter
by E2F/Egr-1 factors.
doi:10.1371/journal.pone.0003316.g009
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bated with 10 mM CM-H2DCFDA (Invitrogen) for 30 min,
followed by incubation with CSE. The fluorescence of oxidized
DCFDA in cell lysates, was measured on an Aminco Bowman
series-2 spectrofluorometer at 490/530 nm ex/em.
Small interfering RNA (siRNA) and GFP-LC3 transfection
Human E2F-4-siRNA was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Human LC3B-siRNA was
designed and manufactured by Dharmacon Research (Layfayette,
CO). The siRNA was transfected into cells by using the
transfection reagent (Santa Cruz). One to two mg of GFP-LC3B
(rat) [26] was transfected into 2610
5 cells using lipofectami-
ne
TM2000 according to the supplier’s protocol (Invitrogen, CA).
HDAC Activity
HDAC activity was measured by using a HDAC Colorimetric
Assay Kit (MBL international, Woburn, MA).
Western blotting
All antibodies were from Santa Cruz, except the anti-LC3B and
anti-cleaved caspase-3 were obtained from Abgent (San Diego,
CA) and Cell Signaling (Beverly, MA), respectively. Western
immunoblot analysis was performed using standard methods.
Chromatin immunoprecipitation (CHIP) assay
The proximal promoter region (2550/21) of the human LC3B
gene was analyzed for transcription factor binding sites. Four
putative Egr-1 and seven E2F factor binding sites were found (See
Figure S1). The primer set 59-GCTCGGGACAAAAGCAGTT-
39 and 59-CCCTGAGGTGACGGTTGT-39 was used to amplify
a 427 bp DNA fragment (2550/2124) of the LC3B promoter
region. After treatment with CSE or TSA, Beas-2B cells were
harvested and subjected to the CHIP assay (Active Motif, Carlsbad
CA), following the manufacturer’s protocol.
Caspase-3 activity assay
The caspase-3 activity of human lung samples was determined
by a Caspase-3 Activity Assay Kit (Calbiochem).
Statistical analysis
Results were expressed as means6SD from at least three
independent experiments. Differences in measured variables
between experimental and control group were assessed by using
the Student’s t test. Statistically significant difference was accepted
at P,0.05.
Supporting Information
Figure S1 Supplement to Materials and Methods
Found at: doi:10.1371/journal.pone.0003316.s001 (0.01 MB
DOC)
Acknowledgments
We thank Dr. Meenakshi Arora for flow cytometry measurements, Yong
Wang for technical assistance, Xue Wang for ROS assay, Emeka Ifedigbo
for coordination of clinical samples, and Dr. Steven Kelsen for helpful
discussion and assistance.
Author Contributions
Conceived and designed the experiments: ZHC HPK AMKC. Performed
the experiments: ZHC HPK SJL KN JL YZ. Analyzed the data: SWR
AMKC. Contributed reagents/materials/analysis tools: FS CFB DS RD
RJL MJS SAY JMP JL YZ. Wrote the paper: ZHC SWR.
References
1. Celli BR, MacNee W, ATS/ERS Task Force (2004) Standards for the diagnosis
and treatment of patients with COPD: a summary of the ATS/ERS position
paper. Eur Respir J 23: 932–946.
2. Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:
269–280.
3. Mayer AS, Newman LS (2001) Genetic and environmental modulation of
chronic obstructive pulmonary disease. Respir Physiol 128: 3–11.
4. Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary
disease: molecular and cellular mechanisms. Eur Respir J 22: 672–688.
5. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, et al. (2007) Gene
expression profiling in patients with chronic obstructive pulmonary disease and
lung cancer. Am J Respir Crit Care Med 177: 402–411.
6. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, et al. (2004)
Comprehensive gene expression profiles reveal pathways related to the
pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci
USA 101: 14895–14900.
7. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, et al. (1996) Luteinizing
hormone deficiency and female infertility in mice lacking the transcription factor
NGFI-A (Egr-1). Science 273: 1219–1221.
8. Yan SF, Pinsky DJ, Mackman N, Stern DM (2000) Egr-1: is it always immediate
and early? J Clin Invest 105: 553–554.
9. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, et al. (2005) Decreased histone
deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352:
1967–1976.
10. Narlikar GJ, Fan HY, Kingston RE (2002) Cooperation between complexes that
regulate chromatin structure and transcription. Cell 108: 475–487.
11. Henson PM, Vandivier RW, Douglas IS (2006) Cell death, remodeling, and repair
in chronic obstructive pulmonary disease? Proc Am Thorac Soc 3: 713–717.
12. Yokohori N, Aoshiba K, Nagai A (2004) Increased levels of cell death and
proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest
125: 626–632.
13. Kasahara Y, Tuder RM, Cool CD, et al. (2001) Endothelial cell death and
decreased expression of vascular endothelial growth factor and vascular
endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care
Med 163: 737–744.
14. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, et al. (2005)
Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like
disease in mice. Nat Med 11: 491–498.
15. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, et al.
(2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.
J Clin Invest 106: 1311–1319.
16. Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin
Invest 115: 2679–2688.
17. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular
mechanisms and biological functions of autophagy. Dev Cell 6: 463–477.
18. Yu L, Alva A, Su H,Dutt P, Freundt S, et al. (2004) Regulation of an ATG7-beclin
1 program of autophagic cell death by caspase-8. Science 304: 1500–1502.
19. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, et al.
(2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death
dependent on autophagy genes. Nat Cell Biol 6: 1221–1228.
20. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, et al. (2005) Autophagy in
chronically ischemic myocardium. Proc Natl Acad Sci USA 102: 13807–13812.
21. Crighton D, Wilkinson S, O’Prey J, Syed N, Smith P, et al. (2006) DRAM, a
p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:
121–134.
22. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besanc ¸on F, Bauvy C, et al.
(2006) NF-kappaB activation represses tumor necrosis factor-alpha-induced
autophagy. J Biol Chem 281: 30373–30382.
23. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, et al. (2005) Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927–939.
24. Boya P, Gonza ´lez-Polo RA, Casares N, Perfettini JL, Dessen P, et al. (2005)
Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25: 1025–1040.
25. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in
cancer development and response to therapy. Nat Rev Cancer 5: 726–734.
26. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3,
a mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J 19: 5720–5728.
27. Klionsky D, et al. (2008) Guidelines for the use and interpretation of assays for
monitoring autophagy in higher eukaryotes. Autophagy 4: 151–175.
28. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, et al. (2006)
Cigarette smoke induces proinflammatory cytokine release by activation of NF-
kappaB and posttranslational modifications of histone deacetylase in macro-
phages. Am J Physiol Lung Cell Mol Physiol 291: L46–L57.
29. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, et al. (2004) Theophylline
restores histone deacetylase activity and steroid responses in COPD macro-
phages. J Exp Med 200: 689–695.
Autophagy in COPD
PLoS ONE | www.plosone.org 12 October 2008 | Volume 3 | Issue 10 | e331630. Shao Y, Gao Z, Marks PA, Jiang X (2004) Apoptotic and autophagic cell death
induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 101:
18030–18035.
31. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D (1998) The
three members of the pocket proteins family share the ability to repress E2F
activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA
95: 10493–10498.
32. Iavarone A, Massague J (1999) E2F and histone deacetylase mediate
transforming growth factor beta repression of cdc25A during keratinocyte cell
cycle arrest. Mol Cell Biol 19: 916–922.
33. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, et al. (2006) E2F-HDAC
complexes negatively regulate the tumor suppressor gene ARHI in breast
cancer. Oncogene 25: 230–239.
34. Dunhill M (1962) Quantitative methods in the study of pulmonary pathology.
Thorax 17: 320–328.
35. Shapiro SD (2004) Smoke gets in your cells. Am J Respir Cell Mol Biol 31:
481–482.
36. Adcock IA, Tsaprouni L, Bhavsar P, Ito K (2007) Epigenetic regulation of
airway inflammation. Curr Opinion Immunol 19: 694–700.
37. Yorimitsu T, Klionsky DJ (2005) Autophagy: molecular machinery for self-
eating. Cell Death Differ 12 Suppl 2: 1542–1552.
38. Landesberg LJ, Ramalingam R, Lee K, Rosengart TK, Crystal RG (2001)
Upregulation of transcription factors in lung in the early phase of postpneumo-
nectomy lung growth. Am J Physiol Lung Cell Mol Physiol 281: L1138–L1149.
39. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, et al. (2004) The role
of autophagy during the early neonatal starvation period. Nature 432:
1032–1036.
40. Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene
essential for early embryonic development, is a haploinsufficient tumor
suppressor. Proc Natl Acad Sci USA 100: 15077–15082.
41. Cann GM, Guignabert C, Ying L, Deshpande N, Bekker JM, et al. (2008)
Developmental expression of LC3alpha and beta: absence of fibronectin or
autophagy phenotype in LC3beta knockout mice. Dev Dyn 237: 187–195.
42. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:
27–42.
43. RiouxJD,XavierRJ,TaylorKD,SilverbergMS,Goyette P,etal.(2007)Genome-
wide association study identifies new susceptibility loci for Crohn disease and
implicates autophagy in disease pathogenesis. Nat Genet 39: 596–604.
44. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide
association scan of nonsynonymous SNPs identifies a susceptibility variant for
Crohn disease in ATG16L1. Nat Genet 39: 207–211.
45. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global
strategy for the diagnosis, management and prevention of chronic obstructive
pulmonary disease: NHLBI/WHO workshop report. Bethesda, MD: National
Heart, Lung, and Blood Institute, 2001. (NIH publication no. 2701).
46. Myerburg MM, Latoche JD, McKenna EE, Stabile LP, Siegfried JS, et al. (2007)
Hepatocyte growth factor and other fibroblast secretions modulate the
phenotype of human bronchial epithelial cells. Am J Physiol Lung Cell Mol
Physiol 292: L1352–L1360.
Autophagy in COPD
PLoS ONE | www.plosone.org 13 October 2008 | Volume 3 | Issue 10 | e3316